Global Drug Discovery Services Markets, 2023-2028: Burgeoning Opportunities with Patent Expiries of Key Biologics and Rising Demand for Specialized Testing Services
17 avr. 2023 09h48 HE
|
Research and Markets
Dublin, April 17, 2023 (GLOBE NEWSWIRE) -- The "Global Drug Discovery Services Market 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global Drug discovery services...
Zunsemetinib (ATI-450) Emerging Drug Insights and Market Forecasts, 2032
13 avr. 2023 10h33 HE
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report...
$13+ Billion Antibody Drug Conjugates Global Market to 2032 - North America was the Largest Region in 2022
13 mars 2023 12h23 HE
|
Research and Markets
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
4 Day Drafting Effective Pharmaceutical Patents Training Course: Explore the Latest Strategies and Gain Useful Insights and Practical Solutions to Your Drafting Issues (May 16-19, 2023)
06 févr. 2023 04h08 HE
|
Research and Markets
Dublin, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The "Drafting Effective Pharmaceutical Patents Training Course" conference has been added to ResearchAndMarkets.com's offering. The highly complex area of...
Outlook on the TIL Therapies Global Market to 2035: by Target Indication, Key Players and Key Geographical Regions
01 févr. 2023 06h33 HE
|
Research and Markets
Dublin, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The "Global TIL Therapies Market : Distribution by Target Indication, Key Players and Key Geographical Regions: Industry Trends and Global Forecasts,...
Outlook on the Monkeypox Treatment Global Market to 2035 - Focus on Therapeutics, Vaccines and Diagnostic Kits
31 janv. 2023 10h38 HE
|
Research and Markets
Dublin, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The "Monkeypox Treatment Market: Focus on Therapeutics, Vaccines and Diagnostic Kits: Distribution by Type of Product, Drug Developers, Drug Candidates,...
Provectus Biopharmaceuticals Releases 2023 Stockholder Letter
09 janv. 2023 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that it had issued a beginning-of-the-year letter for 2023 to the Company’s stockholders, which may be found...
1 Day Fundamentals of Pharmacokinetics Seminar: The Processes that a Drug Undergoes After Administration
30 déc. 2022 05h03 HE
|
Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "Full Day Virtual Seminar on Fundamentals of Pharmacokinetics" webinar has been added to ResearchAndMarkets.com's offering.Pharmacokinetics (PK) and...
Insights on the Bioavailability Enhancement Technologies and Services Global Market to 2035 - Industry Trends and Forecasts
12 déc. 2022 08h18 HE
|
Research and Markets
Dublin, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The "Bioavailability Enhancement Technologies and Services Market by Drug Class, BCS Classification, Bioavailability Enhancement Approach, Dosage Form and...
Provectus Biopharmaceuticals Announces Decision to Not Undertake Reverse Split of Outstanding and Authorized Equities in 2022; Expects to Seek Same Stockholder Approval Again in 2023
12 déc. 2022 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company’s Board of Directors (Board) has decided to not undertake the reverse stock split and...